Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891200 · ClinicalTrials.gov registry record · NA
Impact of a Peer Support Program Amongst COPD Patients and Their Caregivers
A NA study of COPD, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 292
- Enrollment target
- 2
- Study locations
NCT02891200 is a NA study of COPD that has completed, run by Johns Hopkins University. The registered enrollment target is 292 participants, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02891200, a NA study of COPD, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 292 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study is to compare the effectiveness of two health communication and dissemination strategies that are designed to engage patients and family caregivers in successfully managing COPD in 'real-world' settings. Both strategies aim to advance patient understanding of COPD, its treatment options, and self-care tasks; support them in coping with the disease; and enable them to adopt a variety of positive behaviors, including adherence to treatment plans, smoking cessation, joining pulmonary rehabilitation programs, and assuming an active, healthy lifestyle. One strategy relies on the healthcare professional (HCP) as the primary communicator about COPD self-management (HCP arm), whereas the other uses a dual approach that involves both healthcare professionals and peer mentors delivering such communication (HCP plus Peer arm). Peer mentors are COPD patients and caregivers who have successfully managed COPD and have received foundational training on peer mentoring. Specifically, the study aims are to : 1) Conduct a randomized controlled trial in which the 'HCP' and 'HCP plus Peer' strategies are tested in 'real-world' healthcare settings; 2) compare the impact of these strategies on patient satisfaction, experience, activation, self- efficacy, self-care behavior, health status, quality of life, use of Emergency Department (ED) and hospital services, and survival; and, 3) compare the impact of these strategies on caregiver satisfaction, experience, self-efficacy, stress, and coping skills.
Conditions Studied
Interventions
- OTHER Peer support program
- OTHER HCP support
Study Locations (2)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
- Howard County General Hospital - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2019-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02891200
The ClinicalTrials.gov registry entry for NCT02891200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Peer support program is the first listed.
NCT02891200 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02891200 about?
NCT02891200 is a clinical study titled "Impact of a Peer Support Program Amongst COPD Patients and Their Caregivers". The study is to compare the effectiveness of two health communication and dissemination strategies that are designed to engage patients and family caregivers in successfully managing COPD in 'real-world' settings. Both strategies aim to advance patient understanding of COPD, its treatment options, a...
What is the current status of trial NCT02891200?
This trial is currently completed. It is a NA study. The enrollment target is 292 participants. The study started on 2017-04-17. Estimated completion is 2019-11-04.
What conditions does trial NCT02891200 study?
This clinical trial studies the following conditions: COPD.
What interventions are being tested in trial NCT02891200?
The interventions under investigation include: Peer support program (OTHER), HCP support (OTHER).
Who is sponsoring clinical trial NCT02891200?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02891200 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.